Why lithium so often fails patients

An Australian team have found an important genetic clue
eureka

Researchers believe they are closer to knowing why so many bipolar patients don’t respond to lithium treatment.

It’s well known that about 30% of patients are only partially responsive to the drug, more than a quarter show no clinical response, and others have significant side-effects to lithium.